Wolwo Bio-Pharmaceutical rings in new year with first Chinese IPO since ban
HONG KONG – In one of the first issues since Mainland China regulator lifted a ban on initial public offerings (IPOs), Zhejiang Wolwo Bio-Pharmaceutical Co. (SZ: 300357) plans to offer as many as 30 million shares for as much as ¥20.05 (US$3.30) per share.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter